Show simple item record

dc.contributor.authorVölzke, Henry
dc.contributor.authorCaron, Philippe
dc.contributor.authorDahl, Lisbeth
dc.contributor.authorde Castro, João J
dc.contributor.authorErlund, Iris
dc.contributor.authorGaberšček, Simona
dc.contributor.authorGunnarsdottir, Ingibjörg
dc.contributor.authorHubalewska-Dydejczyk, Alicja
dc.contributor.authorIttermann, Till
dc.contributor.authorIvanova, Ludmila
dc.contributor.authorKaranfilski, Borislav
dc.contributor.authorKhattak, Rehman M
dc.contributor.authorKusić, Zvonko
dc.contributor.authorLaurberg, Peter
dc.contributor.authorLazarus, John H
dc.contributor.authorMarkou, Kostas B
dc.contributor.authorMoreno-Reyes, Rodrigo
dc.contributor.authorNagy, Endre V
dc.contributor.authorPeeters, Robin P
dc.contributor.authorPīrāgs, Valdis
dc.contributor.authorPodoba, Ján
dc.contributor.authorRayman, Margaret P
dc.contributor.authorRochau, Ursula
dc.contributor.authorSiebert, Uwe
dc.contributor.authorSmyth, Peter P
dc.contributor.authorThuesen, Betina H
dc.contributor.authorTroen, Aron
dc.contributor.authorVila, Lluís
dc.contributor.authorVitti, Paolo
dc.contributor.authorZamrazil, Vaclav
dc.contributor.authorZimmermann, Michael B
dc.date.accessioned2016-04-20T15:57:24Zen
dc.date.available2016-04-20T15:57:24Zen
dc.date.issued2016-02en
dc.date.submitted2016en
dc.identifier.citationThyroid 2016, 26 (2):189-96en
dc.identifier.issn1557-9077en
dc.identifier.pmid26700864en
dc.identifier.doi10.1089/thy.2015.0543en
dc.identifier.urihttp://hdl.handle.net/2336/606105en
dc.descriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the pageen
dc.description.abstractPrograms initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention.
dc.description.abstractAlthough the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency.
dc.description.abstractMonitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.
dc.description.sponsorshipEUthyroid info:eu-repo/grantAgreement/EC/FP7/634453en
dc.language.isoenen
dc.publisherMary Ann Lieberten
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/634453en
dc.relation.urlhttp://dx.doi.org/10.1089/thy.2015.0543en
dc.rightsclosedAccessen
dc.subjectNUR12
dc.subject.meshCongenital Hypothyroidism/prevention and controlen
dc.subject.meshIodine/deficiencyen
dc.subject.meshEuropeen
dc.titleEnsuring Effective Prevention of Iodine Deficiency Disorders.en
dc.typearticleen
dc.contributor.department[ 1 ] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany [ 2 ] Ctr Hosp Univ Larrey, Dept Endocrinol, Toulouse, France [ 3 ] Natl Inst Nutr & Seafood Res, Human Studies, Bergen, Norway [ 4 ] Hosp Forcas Armadas, Dept Endocrinol, Lisbon, Portugal [ 5 ] Natl Inst Hlth & Welf, Dis Risk Unit, Helsinki, Finland [ 6 ] Univ Med Ctr, Dept Nucl Med, Ljubljana, Slovenia [ 7 ] Univ Iceland, Unit Nutr Res, Reykjavik, Iceland [ 8 ] Landspitali Natl Univ Hosp, Reykjavik, Iceland   Organization-Enhanced Name(s)      Landspitali National University Hospital [ 9 ] Jagiellonian Univ, Coll Med, Dept Endocrinol, Krakow, Poland [ 10 ] Sofia Univ Sv Kliment Ohridski, Fac Med, Sofia, Bulgaria [ 11 ] Ctr Reg Policy Res & Cooperat Studiorum, Skopje, Macedonia [ 12 ] Univ Zagreb, Sch Med, Univ Hosp Ctr Sestre Milosrdnice, Dept Oncol & Nucl Med, Zagreb 41001, Croatia [ 13 ] Aalborg Univ Hosp, Dept Endocrinol, Aalborg, Denmark [ 14 ] Aalborg Univ Hosp, Dept Clin Med, Aalborg, Denmark [ 15 ] Aalborg Univ, Aalborg, Denmark [ 16 ] Cardiff Univ, Inst Mol Med, Cardiff CF10 3AX, S Glam, Wales [ 17 ] Inst Univ Patras Med Sch, Dept Endocrinol, Patras, Greece [ 18 ] Univ Libre Bruxelles, Erasme Hosp, Dept Nucl Med, Brussels, Belgium [ 19 ] Univ Debrecen, Div Endocrinol, Debrecen, Hungary [ 20 ] Erasmus MC, Rotterdam Thyroid Ctr, Dept Internal Med, Rotterdam, Netherlands [ 21 ] Univ Latvia, Dept Internal Med, Riga, Latvia [ 22 ] Slovakian Med Univ, Dept Endocrinol, Bratislava, Slovakia [ 23 ] Univ Surrey, Fac Hlth & Med Sci, Dept Nutr Sci, Guildford GU2 5XH, Surrey, England [ 24 ] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth, Hlth Serv Res & Hlth Technol Assessment, Hall In Tirol, Austria [ 25 ] Natl Univ Ireland, Galway, Ireland [ 26 ] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland [ 27 ] Rigshosp, Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark [ 28 ] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Jerusalem, Israel [ 29 ] Hosp St Joan Despi Moises, Dept Endocrinol & Nutr, Barcelona, Spain [ 30 ] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy [ 31 ] Inst Endocrinol, Prague, Czech Republic [ 32 ] Zurich Dept Hlth Sci & Technol, Swiss Fed Inst Technol, Zurich, Switzerlanden
dc.identifier.journalThyroid : official journal of the American Thyroid Associationen
dc.rights.accessClosed - Lokaðen
html.description.abstractPrograms initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention.
html.description.abstractAlthough the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency.
html.description.abstractMonitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.


This item appears in the following Collection(s)

Show simple item record